Soluble hiv-1 envelope glycoprotein trimers
作者： Richard Wyatt , Viktoriya Dubrovskaya , Francisco Javier Guenaga
DOI:
关键词:
摘要: The present application relates to novel HIV-1 envelope glycoproteins which may be utilized as an vaccine immunogens, antigens for crystallization and the identification of broad neutralizing antibodies. invention encompasses preparation purification immunogenic compositions are formulated into vaccines invention.
glgoo.top参考文章(680)
Angeline Douvas, Glenn Ehresmann, Method of stimulating an immune response to caprine arthritis-encephalitis virus (CAEV) in humans through the administration of CAEV immunogens ,(1996)
Matthew A. Gonda, Gregory J. Tobin, Chimeric Gag pseudovirions ,(1997)
Gary Pignac-Kobinger, Florent Checroune, Eric A. Cohen, Xiao-Jian Yao, Dominique Bergeron, Expression vectors encoding recombinant proteins comprising a VPR/VPX virion incorporation domain for targeting into HIV-1 or HIV-2 virions ,(1995)
Jones M. Hyman, Base dissociation assay ,(1992)
Sachiko Kajigaya, Neal S. Young, Shimada Takashi, Parvovirus protein presenting capsids ,(1994)
John A. Puskas, Keming Song, Jeffrey M. Linnen, David R. Patterson, Oligonucleotide reverse transcription primers for efficient detection of hiv-1 and hiv-2 and methods of use thereof ,(2000)
Florence Boudet, Régis Sodoyer, Tino Krell, Raphaëlle El Habib, Michel Chevalier, Methods for inducing HIV-neutralizing antibodies ,(2003)
William A. Carter, Controlled dsRNA therapy for human viral infections ,(1988)
Yichen Lu, Kevin Killeen, Samuel I. Miller, Salmonella vectors encoding truncated pag fusion protein, method of making, and uses thereof ,(1994)
Peter D. Kwong, Wayne A. Hendrickson, Richard T. Wyatt, Joseph G. Sodroski, Glycosylated modified primate lentivirus envelope polypeptides ,(1998)